person
Pier L. Z.
- Country
- Italy
- Department
- U.O. EmatologiaIstituto "L&A Seràgnoli"-
Research Overview
assignment
93
Clinical Trials ·
- Phase 1b Study of Loncastuximab Tesirine with Anti-cancer Agents in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
- Evaluation of Acalabrutinib Monotherapy and Combination with Rituximab in Relapsed/Refractory Marginal Zone Lymphoma: A Phase 1b/2 Open-label Study
- Phase 1b Study of Mosunetuzumab and Glofitamab with CC-220 and CC-99282 in B-Cell Non-Hodgkin Lymphoma Patients
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
326
Sites with multiple studies
Has run more than one trial at 326 of 516 partner sites.
Specializations
Lymphoma Research
Specializes in investigating novel treatments for various B-cell lymphomas and T-cell lymphomas, with particular focus on therapeutic approaches for aggressive and indolent forms.
- Diffuse Large B-Cell Lymphoma
- Mantle Cell Lymphoma
- Follicular Lymphoma
- Peripheral T-Cell Lymphoma
Leukemia Studies
Conducts research in chronic lymphocytic leukemia and related conditions, exploring innovative therapeutic combinations and targeted treatments.
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Large Granular Lymphocytic Leukemia
- Hairy Cell Leukemia
Advanced Therapies
Focuses on evaluating targeted immunotherapies and cell-based treatments for hematologic malignancies.
- CAR T-Cell Therapy
- Monoclonal Antibodies
- BTK Inhibitors
- Novel Drug Combinations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.